AVX754 (a New Nucleoside Reverse Transcriptase Inhibitor [NRTI]) to Treat Drug-resistant HIV
Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
The study will measure how safe and effective AVX754 (a new drug for the treatment of HIV) is
in treating HIV-1 infected people who have failed treatment with lamivudine.